Text size :

Cancers, Dorigo (AstraZeneca Italy): “With End of Silence we want to give a new narrative”

ADNKRONOS

November 16, 2026

Rome, Nov 16. (Adnkronos Health) – “The End of Silence campaign stems from the need for a new narrative of cancer: until a few years ago, when a person received a diagnosis, it was experienced as a death sentence. We want to communicate differently because in oncology, innovation has had a concrete impact on people’s lives.” This is explained by Alessandra Dorigo, Head of Oncology at AstraZeneca Italy, as part of the End of Silence campaign, an AstraZeneca initiative, in collaboration with patient associations IPOP and WALCE, to change the narrative on oncological diseases in Italy, moving from the idea of “sentence” to a perspective of life, care, and hope, which from November 9 to 22 will be active at Termini Station in Rome with an installation dedicated to lung cancer. The initiative uses the lyrics of Silvia Salemi’s song as visual micro-stories to tell tales of care and progress.

“In particular, we have an important data point in Italy that tells us that cancer-related mortality has decreased by 9% in the last ten years, thanks to research, prevention, and scientific innovation – she explains – If we look at an even more specific pathology, where AstraZeneca has been committed for many years, namely lung cancer, this figure is truly impressive: -24% reduction in mortality in the last ten years.”

“With End of Silence, therefore, we want to contribute to a new narrative around cancer. We recently returned from the European Congress of Medical Oncology of Esmo (European Society For Medical Oncology), where we increasingly felt the sense of urgency to bring these innovations to our patients – emphasizes Dorigo – This innovation must arrive soon not only in Europe, but also in Italy, and requires everyone’s contribution because today we live in a different geopolitical context, where Europe is losing competitiveness compared to the American or Chinese poles.”

“The keyword is sharing and collaboration: together we can make a difference. The Italian health ecosystem is an important ecosystem, because it generates 12.5% of GDP and within it operate various actors – states Dorigo – not only pharmaceutical companies, but also scientific societies, the academic world, institutions, and patient associations.” “An excellent example of this collaboration is precisely this campaign, carried out together with Walce (Women Against Lung Cancer) and Ipop (Together for Lung Oncology Patients), two associations committed to raising awareness about lung cancer,” she concludes.

Jiji Press

Related

Page TOP